Drug Controller General permits clinical trial of convalescent plasma in COVID-19 patients

The central drug regulator has given its go-ahead to a proposal by the Indian Council of Medical Research for the clinical trial of convalescent plasma in COVID-19 patients, as per the protocol developed by ICMR.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news